Glucotrack announces the appointment of luis malavÉ to chair of the board of directors

Rutherford, nj, feb. 13, 2024 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes announced today that luis malavÉ has been elected as chairman of its board of directors, effective immediately.

GCTK Ratings Summary

GCTK Quant Ranking